Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate

Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate

US Patent 7888370 · Granted Feb 15, 2011

Estimated economic value: $37,710,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compositions and methods of making on demand solid dosage formula2025
Histone deacetylase inhibitors and compositions and methods of use thereof2019
Sildenafil sublingual spray formulations2018
Histone deacetylase inhibitors and compositions and methods of use thereof2018
Histone deacetylase inhibitors and compositions and methods of use thereof2018
Alternating sympathomimetic therapy for the treatment of respiratory ailments2018
Methods and systems for preparing dough-based products2018
Histone deacetylase inhibitors and compositions and methods of use thereof2018
Histone deacetylase inhibitors and compositions and methods of use thereof2018
Histone deacetylase inhibitors and compositions and methods of use thereof2018
Sildenafil sublingual spray formulations2017
Histone deacetylase inhibitors and compositions and methods of use thereof2017